Tilray Brands, Inc.
TLRY$1.30B
Small CapNASDAQMedicinal Chemicals & Botanical Products🇺🇸North AmericaNEW YORK1.6K employees
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jan 1, 2027
42wMarket Overview
Stock performance and key metrics
TLRY News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
High THC/Low CBD Cannabis | Phase 2 | Posttraumatic Stress Disorder | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply